These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. EFFECTS OF MAGNESIUM SULFATE, CALCIUM GLUCONATE, POTASSIUM CHLORIDE AND AMMONIUM CHLORIDE ON THE URINARY EXCRETION OF MAGNESIUM IN PATIENTS WITH IDIOPATHIC CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE. LAZZARA RK, YUN TK, BURCH GE. Am J Med Sci; 1965 Aug; 250():193-8. PubMed ID: 14331952 [No Abstract] [Full Text] [Related]
24. The effects of a reduced-sodium, high-potassium salt substitute on food taste and acceptability in rural northern China. Li N, Prescott J, Wu Y, Barzi F, Yu X, Zhao L, Neal B, China Salt Substitute Study Collaborative Group. Br J Nutr; 2009 Apr; 101(7):1088-93. PubMed ID: 18710605 [Abstract] [Full Text] [Related]
25. Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water. Cohen H, Sherer Y, Shaish A, Shoenfeld Y, Levkovitz H, Bitzur R, Harats D. Biol Trace Elem Res; 2002 Apr; 90(1-3):251-9. PubMed ID: 12666839 [Abstract] [Full Text] [Related]
26. [Role of the patho-autokinetic element in the pathogenesis of disturbances of myocardial lipid composition induced by experimental atherogenic dyslipoproteinemia]. Kalinkin MN. Patol Fiziol Eksp Ter; 1991 Apr; (5):14-7. PubMed ID: 1806882 [Abstract] [Full Text] [Related]
27. The effect of ACE inhibitors on atheroma formation is potentiated by association with a calcium channel blocker. A biochemical and ultrastructural study. Raicu M, Pojoga L, Simionescu N, Simionescu M. J Submicrosc Cytol Pathol; 1997 Jul; 29(3):317-28. PubMed ID: 9267040 [Abstract] [Full Text] [Related]
28. [Effect of acipimox on diabetes mellitus-associated hyperlipoproteinemia]. Paragh G, Balogh Z, Boda J, Mohácsi A, Juhász A, Leövey A. Orv Hetil; 1993 Jan 17; 134(3):121-4. PubMed ID: 8421622 [Abstract] [Full Text] [Related]
29. [Acid-base imbalance and its correction during intensive care]. Marenović T, Milić D, Mihailović D, Anicić S. Vojnosanit Pregl; 1973 Jan 17; 30(5):354-8. PubMed ID: 4772836 [No Abstract] [Full Text] [Related]
30. Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy. Vega GL. Endocrinol Metab Clin North Am; 2004 Sep 17; 33(3):525-44, vi. PubMed ID: 15262295 [Abstract] [Full Text] [Related]
31. Serum electrolytes in children with neurocardiogenic syncope treated with fludrocortisone and salt. Salim MA, DiSessa TG. Am J Cardiol; 1996 Jul 15; 78(2):228-9. PubMed ID: 8712150 [Abstract] [Full Text] [Related]
32. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats. Deepa PR, Varalakshmi P. Clin Chim Acta; 2005 May 15; 355(1-2):119-30. PubMed ID: 15820486 [Abstract] [Full Text] [Related]
33. Flavonoid-induced reduction of ENaC expression in the kidney of Dahl salt-sensitive hypertensive rat. Aoi W, Niisato N, Miyazaki H, Marunaka Y. Biochem Biophys Res Commun; 2004 Mar 19; 315(4):892-6. PubMed ID: 14985096 [Abstract] [Full Text] [Related]
34. Dyslipidemia and atherosclerosis. A forecast of pharmaceutical approaches. Gotto AM. Circulation; 1993 Apr 19; 87(4 Suppl):III54-9. PubMed ID: 8462181 [Abstract] [Full Text] [Related]
35. [Effects of water hardness and salt intake on the formation and disappearance of experimental atherosclerosis]. Zhang ST. Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar 19; 27(2):97-100. PubMed ID: 8354115 [Abstract] [Full Text] [Related]
36. [The alimentary approach to the pharmacological correction of mineral metabolism and related functions]. Branchevskiĭ LL. Eksp Klin Farmakol; 1993 Mar 19; 56(6):37-8. PubMed ID: 8111295 [Abstract] [Full Text] [Related]
37. Serum electrolyte, serum protein, serum fat and renal responses to a dietary sodium challenge: allostasis and allostatic load. van Berge-Landry H, James GD. Ann Hum Biol; 2004 Mar 19; 31(4):477-87. PubMed ID: 15513697 [Abstract] [Full Text] [Related]
38. [Present status of fibrates in the treatment of hyperlipoproteinemias]. Soska V. Vnitr Lek; 1999 Jul 19; 45(7):438-40. PubMed ID: 11045165 [Abstract] [Full Text] [Related]
39. [The correction of the pathological changes in the neuroendocrine system in hyperlipoproteinogenic microangiopathy]. Pozdniakov OM, Kobozeva LP, Michunskaia AB, Khabarina IIu, Klimenko ED. Patol Fiziol Eksp Ter; 1997 Jul 19; (2):9-11. PubMed ID: 9235544 [Abstract] [Full Text] [Related]
40. Antiatherogenic effect of taurine in high fat diet fed rats. Sethupathy S, Elanchezhiyan C, Vasudevan K, Rajagopal G. Indian J Exp Biol; 2002 Oct 19; 40(10):1169-72. PubMed ID: 12693699 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]